Publications
FILTER BY TYPE
Publication
GAVI
March 9, 2022
Conclusions from the 22nd DCVMN Annual General Meeting | Gavi, the Vaccine Alliance
Scientific Article
The Lancet
February 28, 2022
Accelerating research and development of new vaccines against tuberculosis: a global roadmap
Scientific Article
Elsevier, PubMed
February 23, 2022
How to accelerate the supply of vaccines to all populations worldwide? Part II: Initial industry lessons learned and detailed technical reflections leveraging the COVID-19 situation
Scientific Article
Elsevier
February 22, 2022
How to accelerate the supply of vaccines to all populations worldwide? Part I: Initial industry lessons learned and practical overarching proposals leveraging the COVID-19 situation
Publication
BIO, DCVMN International & IFPMA
December 16, 2021
Press release: 11 billion COVID-19 vaccines produced in 2021 has resulted in the biggest immunization campaign in human history and 2022 will require more and better vaccine redistribution and innovation
Scientific Article
Elsevier
October 20, 2021
The importance of vaccine stockpiling to respond to epidemics and remediate global supply shortages affecting immunization: strategic challenges and risks identified by manufacturers
Scientific Article
Elsevier
August 23, 2021
Developing-country vaccine manufacturers’ technical capabilities can make a difference in global immunization
Scientific Article
Elsevier
August 16, 2021
COVID-19 vaccine capacity: Challenges and mitigation – The DCVMN perspective
Statement
IMCRA
July 7, 2021
Biopharmaceutical Industry Statement on ICMRA workshop on enabling manufacturing capacity in the COVID-19 pandemic
Our sponsors
Our sponsors
Our sponsors
Our sponsors
